Progenity Provides Corporate Updates and Reports Fourth Quarter and Full-Year 2020 Financial Results

NEXT STORY
Idera Pharmaceuticals Announces Results From ILLUMINATE-301 Trial of Tilsotolimod + Ipilimumab in anti-PD-1 Refractory Advanced Melanoma
PREV STORY
Adverum Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Clementia Appoints Industry Executive Shawn Tomasello to its Board of Directors

Accomplished Biopharma Leader Brings Over 30 Years of Experience Leading Strategic and Commercial EffortsMONTREAL, ...

author_avatar
NASDAQ Market News

Clearside Biomedical, Inc. to Present at the 2016 Wedbush PacGrow Healthcare Conference

ALPHARETTA, Ga., Aug. 10, 2016 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage ...

author_avatar
NASDAQ Market News

SELLAS Life Sciences Announces Completion of Enrollment in Phase 2 Randomized Controlled Clinical Study of Nelipepimut-S Plus Trastuzumab in High-risk, High-expression HER2 Breast Cancer Patients

Data Expected in Fourth Quarter of 2019 Second Clinical Study of Nelipepimut-S Plus Trastuzumab ...

author_avatar
NASDAQ Market News